Loading…
Sectoral / Thematic · DSP Mutual Fund · AMFI code 145453DSP Healthcare Fund
Disclosed for 94 months, Dec 2018 to Sep 2026.
Portfolio value
₹3,144 Cr
up ₹69.7 Cr vs Sep 2025
- Stocks held
- 29
- unchanged
- Top 10 weight
- 63.3%
- of the portfolio in its ten largest
- Cash & debt
- 1.3%
- cash, money market and debt
- Moves this month
- 0 in · 0 out
- added to 10, trimmed 9
DSP Healthcare Fund is an active equity fund in the Sectoral / Thematic category from DSP Mutual Fund. In October 2025 it disclosed 29 stocks worth ₹3,144 Cr, up ₹69.7 Cr from Sep 2025. Its largest positions were Cipla Limited (8.6%), Sun Pharmaceutical Industries Limited (8.3%), Suven Pharmaceuticals Limited (7.1%); the ten largest together made up 63.3% of the portfolio, and Pharmaceuticals & Biotechnology was the biggest sector at 66.2% of its equity. Cash and debt stood at 1.3%. Compared with Sep 2025 the fund entered 0 new stocks and exited 0.
Against 226 other Sectoral / Thematic funds
Concentration
89%
Top-10 weight is higher than 89% of peers
Breadth
12%
Holds more stocks than 12% of peers
Cash
17%
Holds more cash than 17% of peers
Holdings in October 2025
Download CSVEvery line the fund disclosed, with the change against Sep 2025. Click a column to sort; click a company to see every fund that owns it.
- Weight
- 8.55%
- Δ weight
- down 0.21 pts
- Value
- ₹269 Cr
- Δ value
- down ₹36 L
- Status
- Held
- Weight
- 8.26%
- Δ weight
- up 0.29 pts
- Value
- ₹260 Cr
- Δ value
- up ₹14.8 Cr
- Status
- Added
- Weight
- 7.11%
- Δ weight
- down 0.79 pts
- Value
- ₹224 Cr
- Δ value
- down ₹19.4 Cr
- Status
- Trimmed
- Weight
- 6.86%
- Δ weight
- down 0.53 pts
- Value
- ₹216 Cr
- Δ value
- down ₹11.5 Cr
- Status
- Trimmed
- Weight
- 6.73%
- Δ weight
- up 0.65 pts
- Value
- ₹212 Cr
- Δ value
- up ₹24.8 Cr
- Status
- Added
- Weight
- 5.65%
- Δ weight
- down 0.32 pts
- Value
- ₹178 Cr
- Δ value
- down ₹5.8 Cr
- Status
- Trimmed
- Weight
- 5.59%
- Δ weight
- up 1.19 pts
- Value
- ₹176 Cr
- Δ value
- up ₹40.6 Cr
- Status
- Added
- Weight
- 5.23%
- Δ weight
- up 0.47 pts
- Value
- ₹165 Cr
- Δ value
- up ₹18 Cr
- Status
- Added
- Weight
- 4.76%
- Δ weight
- up 0.06 pts
- Value
- ₹150 Cr
- Δ value
- up ₹5.3 Cr
- Status
- Added
- Weight
- 4.58%
- Δ weight
- up 0.13 pts
- Value
- ₹144 Cr
- Δ value
- up ₹7.3 Cr
- Status
- Added
- Weight
- 4.08%
- Δ weight
- down 0.11 pts
- Value
- ₹128 Cr
- Δ value
- down ₹56 L
- Status
- Held
- Weight
- 3.36%
- Δ weight
- up 0.07 pts
- Value
- ₹106 Cr
- Δ value
- up ₹4.4 Cr
- Status
- Added
- Weight
- 3.32%
- Δ weight
- up 0.04 pts
- Value
- ₹105 Cr
- Δ value
- up ₹3.5 Cr
- Status
- Added
- Weight
- 3.12%
- Δ weight
- down 0.14 pts
- Value
- ₹98.2 Cr
- Δ value
- down ₹2.2 Cr
- Status
- Trimmed
- Weight
- 2.94%
- Δ weight
- down 0.10 pts
- Value
- ₹92.5 Cr
- Δ value
- down ₹1.1 Cr
- Status
- Trimmed
- Weight
- 2.87%
- Δ weight
- down 0.20 pts
- Value
- ₹90.3 Cr
- Δ value
- down ₹4.1 Cr
- Status
- Trimmed
- Weight
- 2.83%
- Δ weight
- up 0.41 pts
- Value
- ₹89 Cr
- Δ value
- up ₹14.4 Cr
- Status
- Added
- Weight
- 2.25%
- Δ weight
- down 0.38 pts
- Value
- ₹70.7 Cr
- Δ value
- down ₹10 Cr
- Status
- Trimmed
- Weight
- 1.65%
- Δ weight
- up 0.01 pts
- Value
- ₹51.9 Cr
- Δ value
- up ₹1.5 Cr
- Status
- Added
- Weight
- 1.53%
- Δ weight
- up 0.05 pts
- Value
- ₹48.1 Cr
- Δ value
- up ₹2.5 Cr
- Status
- Added
- Weight
- 1.33%
- Δ weight
- down 0.02 pts
- Value
- ₹41.8 Cr
- Δ value
- up ₹39 L
- Status
- Added
- Cash, TREPS & receivables
- Weight
- 1.31%
- Δ weight
- down 0.74 pts
- Value
- ₹41 Cr
- Δ value
- down ₹21.8 Cr
- Status
- Trimmed
- Weight
- 1.28%
- Δ weight
- down <0.01 pts
- Value
- ₹40.1 Cr
- Δ value
- up ₹81 L
- Status
- Added
- Weight
- 1.10%
- Δ weight
- down 0.12 pts
- Value
- ₹34.7 Cr
- Δ value
- down ₹2.9 Cr
- Status
- Trimmed
- Weight
- 0.82%
- Δ weight
- up 0.12 pts
- Value
- ₹25.7 Cr
- Δ value
- up ₹4.3 Cr
- Status
- Added
- Global X Funds - Global X Genomics & Biotechnology ETFFund units
- Weight
- 0.79%
- Δ weight
- up 0.10 pts
- Value
- ₹24.7 Cr
- Δ value
- up ₹3.6 Cr
- Status
- Added
- Weight
- 0.65%
- Δ weight
- down <0.01 pts
- Value
- ₹20.6 Cr
- Δ value
- up ₹30 L
- Status
- Added
- Weight
- 0.48%
- Δ weight
- up 0.01 pts
- Value
- ₹14.9 Cr
- Δ value
- up ₹63 L
- Status
- Added
- Weight
- 0.47%
- Δ weight
- down 0.01 pts
- Value
- ₹14.7 Cr
- Δ value
- up ₹10 L
- Status
- Added
- Weight
- 0.28%
- Δ weight
- down 0.02 pts
- Value
- ₹8.8 Cr
- Δ value
- down ₹31 L
- Status
- Trimmed
- Weight
- 0.23%
- Δ weight
- up 0.08 pts
- Value
- ₹7.1 Cr
- Δ value
- up ₹2.5 Cr
- Status
- Added
What changed, Sep 2025 to Oct 2025
New New positions (0)
None.
Exited Exited (0)
None.
Added Biggest additions
- Illumina Incup ₹40.6 Cr (+1.19% pts)
- Laurus Labs Limitedup ₹24.8 Cr (+0.65% pts)
- Sai Life Sciences Limitedup ₹18 Cr (+0.47% pts)
- Sun Pharmaceutical Industries Limitedup ₹14.8 Cr (+0.29% pts)
- Intuitive Surgical Incup ₹14.4 Cr (+0.41% pts)
Sectors
Which sectors the fund is moving towards and away from, and where its money sits now. Shares are of the fund’s classified equity holdings, so they add up to 100%.
Where the weight moved
Compared with
Since Sep 2025, the weight rose most in Healthcare Services (+1.4 pts) and Healthcare Equipment & Supplies (+0.5 pts), and fell most in Pharmaceuticals & Biotechnology (−1.5 pts) and Pharmaceuticals (−0.4 pts).
- Healthcare Services17.2% → 18.6%+1.4 pts
- Healthcare Equipment & Supplies7.4% → 7.9%+0.5 pts
- Pharmaceuticals & Biotechnology67.7% → 66.2%−1.5 pts
- Pharmaceuticals5.7% → 5.4%−0.4 pts
A sector’s weight changes when the fund buys or sells, and also when its shares rise or fall in price, so a change is not by itself a sign of buying or selling.
Main sectors’ weights over time
| Sector | Oct 2022 | Oct 2024 | Apr 2025 | Jul 2025 | Sep 2025 | Oct 2025 |
|---|---|---|---|---|---|---|
| Pharmaceuticals & Biotechnology | 61.4% | 66.4% | 65.9% | 67.5% | 67.7% | 66.2% |
| Healthcare Services | 23.3% | 18.0% | 17.6% | 17.4% | 17.2% | 18.6% |
| Healthcare Equipment & Supplies | 6.4% | 8.1% | 8.9% | 6.9% | 7.4% | 7.9% |
| Pharmaceuticals | 5.6% | 5.6% | 5.6% | 6.1% | 5.7% | 5.4% |
| Insurance | 2.4% | 1.5% | 1.6% | 1.5% | 1.5% | 1.6% |
| Retailing | 1.0% | 0.4% | 0.5% | 0.6% | 0.5% | 0.5% |
Allocation in Oct 2025change vs Sep 2025
- Pharmaceuticals & Biotechnology (14)66.2%▼ 1.5 pts
- Healthcare Services (7)18.6%▲ 1.4 pts
- Healthcare Equipment & Supplies (3)7.9%▲ 0.5 pts
Cash and debt
The share of the portfolio not in shares: cash and net receivables, money-market instruments and bonds, as disclosed each month. Cash can dip below zero when payables, often on derivative positions, exceed it. A change here describes what the fund did; it is not a signal.
Cash & debt, Oct 2025
1.3%
▼ 0.7 pts vs Sep 2025
- Cash alone
- 1.3%
- cash and net receivables
- A year earlier
- 2.7%
- Oct 2024 · now ▼ 1.4 pts
- Last 12 months
- 0.1% – 4.8%
- lowest to highest · record 28.6% in Dec 2018
History
Disclosed portfolio value by month, with the stocks the fund entered and exited against its previous disclosure. Every month is a link to that portfolio.